Notably, a number of human mutations in SLC6A1 encoding GAT-1 leads to reduced GABA transport activity, and some of the mutations are associated with CAE or clinical conditions associated with absence seizures (160–164). The gene discussed is SLC6A1; the disease is Generalized non-motor (absence) seizure.